Evidence map›Paper›PMID 38077629›Full record

ArticleInfectious medicine2022

Advanced approach for antifungal susceptibility and characterization of resistance properties in clinical and environmental isolates of

Shayanki Lahiri, Nagarathna Chandrashekar

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infectious medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Repositioning Antimicrobial Peptides Against WHO-Priority Fungi.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  2. Review
  3. Article
  4. Antifungal Resistance in Cryptococcal Infections.Pathogens (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Shayanki LahiriDepartment of Neuromicrobiology, National Institute of Mental Health and Neuro Sciences, Bangalore, Karnataka, India.
Nagarathna ChandrashekarDepartment of Neuromicrobiology, National Institute of Mental Health and Neuro Sciences, Bangalore, Karnataka, India.
National Institute of Mental Health and Neurosciences · INUniversity of Michigan–Ann Arbor · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Meningitis due to Methods: Eighty clinical (54 Results: Conclusions: This pioneering study provides an insight into the sensitivity patterns of clinical and environmental cryptococcal isolates from south India. The recent emergence of AmB-resistance may transpire as a challenge for the clinicians. As the clinical and environmental isolates are phylogenetically evolved from

Indexed as

Amphotericin B resistanceAntifungal susceptibilityClinical isolatesCnAFR1Cryptococcus neoformans/gattiiEnvironmental isolates

Identifiers

PMID38077629
PMCPMC10699700
OpenAlexW4293537965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.